- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 223/26 - Dibenz [b, f] azepinesHydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a double bond between positions 10 and 11
Patent holdings for IPC class C07D 223/26
Total number of patents in this class: 43
10-year publication summary
|
3
|
5
|
2
|
2
|
6
|
2
|
4
|
1
|
2
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Crius Technology Group, Inc. | 22 |
11 |
| Merck Patent GmbH | 5752 |
4 |
| NGK Insulators, Ltd. | 5146 |
4 |
| Icahn School of Medicine at Mount Sinai | 977 |
3 |
| FUJIFILM Corporation | 29839 |
2 |
| Life Technologies Corporation | 3351 |
2 |
| Miralinc Pharma, Inc. | 2 |
2 |
| Avantium Holding B.V. | 8 |
1 |
| Emory University | 1664 |
1 |
| EnVivo Pharmaceuticals, Inc. | 27 |
1 |
| F.I.S. Fabbrica Italiana Sintetici S.p.A. | 131 |
1 |
| Jubilant Organosys Limited | 22 |
1 |
| Matrix Laboratories Limited | 98 |
1 |
| MethylGene Inc. | 40 |
1 |
| Mylan Laboratories Limited | 180 |
1 |
| National University Corporation Chiba University | 505 |
1 |
| Rohm and Haas Electronic Materials Korea Ltd. | 331 |
1 |
| The United States of America as represented by the Department of Veterans Affairs | 298 |
1 |
| The University of Tokyo | 4250 |
1 |
| Zhejiang Jiuzhou Pharmaceutical Co., Ltd. | 70 |
1 |
| Other owners | 2 |